Clin2
NCT07578220Possibly a fitRecruiting

Ultrasound-guided acupotomy for ankylosing spondylitis

Ankylosing Spondylitis

Part of Bones, joints & muscles clinical trials.

This study tests an ultrasound-guided needle procedure called acupotomy to treat ankylosing spondylitis, a type of arthritis that affects the spine. It might help reduce pain and improve movement.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
60 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • Be between 18 and 75 years old
  • Have a diagnosis of ankylosing spondylitis
  • Have moderate to severe back pain and stiffness (BASDAI score of 4 or more on a scale of 0-10)
  • Be willing to try a needle procedure and follow the study plan

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06833112Not yet recruiting· Phase 4
Combination biologic therapy for ankylosing spondylitis

This trial tests whether combining two biologic medications (adalimumab and secukinumab) can better relieve symptoms of ankylosing spondylitis, a type of arthritis that affects the spine. It may help if you have not responded well to standard nonsteroidal anti-inflammatory drugs (NSAIDs) and you have active disease.

Guiyang, Guizhou
NCT07632599Not yet recruiting· Phase 1
Stem cell treatment for active ankylosing spondylitis

This trial tests whether a single infusion of stem cells from a healthy donor's bone marrow can help reduce inflammation and pain in people with active ankylosing spondylitis. If you are young and have not been helped by standard treatments, this study might offer a new option.

Shenzhen, Guangdong
NCT07396194Not yet recruiting
Study of ankylosing spondylitis treatment options

This study looks at treatments for people with ankylosing spondylitis, a type of arthritis that affects the spine. It aims to find better ways to manage symptoms and improve quality of life.

NCT07534644Not yet recruiting· Phase 1/Phase 2
Stem cell treatment for ankylosing spondylitis

This study tests a new treatment using umbilical cord stem cells given by injection to help reduce inflammation and improve symptoms of ankylosing spondylitis. It is for people who have not gotten enough relief from standard medications, including biologics.

NCT07237568Recruiting· Phase 3
Testing LNK01001 for active ankylosing spondylitis

This trial tests a new oral medication called LNK01001 for adults with active ankylosing spondylitis. It aims to reduce pain, stiffness, and inflammation when standard NSAID treatments no longer help.

Beijing
NCT05962762Not yet recruiting· Phase 1
Umbilical cord stem cells for ankylosing spondylitis

This trial tests whether a single infusion of stem cells from donated umbilical cord tissue is safe and well-tolerated in people with active ankylosing spondylitis (AS). It may reduce inflammation and help control symptoms when standard treatments are not working well enough.

Hear when a new Ankylosing Spondylitis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.